| Catalog Number |
365975 |
| Medical Device Problem Code |
Coagulation in Device or Device Ingredient (1096)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
08/07/2024
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported while analyzing blood samples collected in bd microtainer® k2e tubes, the blood samples coagulated.This occurred ten (10) times.The blood samples were recollected.There was no report of adverse impact to patients or users.
|
| |
|
Additional Manufacturer Narrative
|
|
The following fields were updated due to additional information: d9: device available for evaluation: yes.H.3 device eval by manufacturer? yes.D9: returned to manufacturer on: 09-sep-2024.Investigation summary: material #: 365975.Lot/batch #: 4044896.Bd received 50 samples for investigation.The samples were evaluated by visual examination for presence of additive and 15 samples underwent titration testing for quantity of additive and the indicated failure mode for clotting with the incident lot was not observed.Additionally, 50 retention samples from bd inventory were evaluated by visual examination for presence of additive and 15 retention samples underwent titration testing for quantity of additive and no issues were observed relating to clotting as all samples met specifications.Complaints for sample quality are under statistical control for the month of august 2024.At this time, further testing is not indicated.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode clotting.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.Bd quality will continue to monitor sample quality complaints.
|
| |
|
Event or Problem Description
|
|
It was reported while analyzing blood samples collected in bd microtainer® k2e tubes, the blood samples coagulated.This occurred ten (10) times.The blood samples were recollected.There was no report of adverse impact to patients or users.
|
| |
|
Search Alerts/Recalls
|